Comparison of the Effects of Phenol Neurolysis and Conventional Radiofrequency Thermocoagulation Applied to the Genicular Nerves on Pain in Patients Who Underwent Knee Arthroplasty: A Prospective, Controlled Study

Clicks: 4
ID: 325479
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #36 of 56 articles by views in regional anesthesia and pain medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Objective This study aimed to compare conventional radiofrequency thermocoagulation (RFT) with chemical neurolysis in patients who underwent knee arthroplasty and continued to experience pain. Materials and Methods This was a prospective, quasi-randomized controlled trial. A total of 109 patients who underwent knee arthroplasty were evaluated and assigned to two groups according to the interventional procedures applied to the genicular nerves: Group 1 included patients who underwent conventional RFT, and Group 2 included patients who underwent chemical neurolysis of the genicular nerves using phenol. The Numeric Rating Scale (NRS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) were used to assess pain intensity before the procedure and at 1, 3, and 6-month follow-ups. Results The demographic and clinical characteristics were similar between the conventional RFT and phenol groups. At one month, the mean NRS was 4.09±0.73 in the RFT group and 3.67±0.73 in the phenol group, significantly lower in the phenol group (p = 0.015)[d = 0.503; 95% CI]. The mean NRS scores were 5.57±0.81 and 4.64±0.75, respectively, at the third month (p < 0.001)[d:1.195 95%CI], and 6.52±1.38 and 5.02±1.46 at the sixth month (p < 0.001)[d:1.055 95%CI]. At three months, the NRS ≥50% improvement rate was 29.6% in the RFT group and 49.1% in the phenol group, with a significant difference in favor of the phenol group (p = 0.038)[OR:2.290 95% CI]. At six months, the NRS ≥50% improvement rate was 18.5% and 43.6%, respectively, and the difference was statistically significant in favor of the phenol group (p = 0.005)[OR:3.406 95% CI]. NRS≥30% improvement rate was similar at 1 month, at 98.1% in the RFT group and 98.2% in the phenol group (p = 1.000)[OR: 1.019 95% CI]. At three months, these rates were 83.3% and 90.9%, respectively, with no statistically significant difference (p = 0.237)[OR: 2.000 95% CI]. At six months, NRS ≥30% improvement was observed in 72.2% of the RFT group and 87.3% of the phenol group, with a borderline statistically significant difference (p = 0.050)[OR: 2.637 95% CI]. The complication rate was 3.7% in the RFT group and 5.5% in the phenol group, with no significant difference between the two groups (p = 1.000) [OR: 1.500 95% CI]. Conclusion Phenol neurolysis and conventional RFT of the genicular nerves are effective treatments for patients with persistent pain after knee arthroplasty. The results demonstrating the short-term efficacy of phenol neurolysis in patients undergoing arthroplasty should be supported by long-term follow-up studies.
Reference Key
openalex_W7203837045 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Devran Ertilav, Esra Ertilav
Journal regional anesthesia and pain medicine
Year 2026
DOI
10.1093/pm/pnag104
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.